These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8527015)

  • 1. Pharmacoepidemiology in practice. Current status and future trends.
    Alvarez-Requejo A; Porta M
    Drug Saf; 1995 Jul; 13(1):1-7. PubMed ID: 8527015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoepidemiology and gastroenterology: a close couple.
    Leufkens HG
    Scand J Gastroenterol Suppl; 2000; (232):105-8. PubMed ID: 11232486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some observations on pharmacoepidemiology in Europe.
    van Boxtel CJ; Wang G
    Neth J Med; 1997 Dec; 51(6):205-12. PubMed ID: 9499691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of risk measures in pharmacoepidemiology with tips for statisticians in the pharmaceutical industry.
    Quartey G; Wang J; Kim J
    Pharm Stat; 2011; 10(6):548-53. PubMed ID: 22127819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of pharmacoepidemiology research in postmarketing surveillance and anesthesia practice/critical care medicine.
    Grasela TH; Watkins WD; Hug CC; McLeskey CH; Nahrwold ML; Roizen MF; Stanley TH; Thisted RA; Walawander CA; White PF
    Anesth Analg; 1993 Oct; 77(4 Suppl):S44-50. PubMed ID: 8214697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making.
    Etminan M; Gill S; Fitzgerald M; Samii A
    J Clin Pharmacol; 2006 Jan; 46(1):6-9. PubMed ID: 16397278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status, and future prospects of pharmaco-epidemiology and post-marketing surveillance in Saudi Arabia: A review of literature.
    El-Metwally A
    Saudi Pharm J; 2018 Jul; 26(5):629-633. PubMed ID: 29989016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of pharmacovigilance: a personal view.
    Edwards IR
    Eur J Clin Pharmacol; 2008 Feb; 64(2):173-81. PubMed ID: 18172624
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacoepidemiology: an another kind of drug surveillance].
    Pariente A
    Bull Acad Natl Med; 2015; 199(2-3):275-9. PubMed ID: 27476309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interface between pharmacoepidemiology and pharmacogenetics.
    Maitland-van der Zee AH ; de Boer A ; Leufkens HG
    Eur J Pharmacol; 2000 Dec; 410(2-3):121-130. PubMed ID: 11134664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who is now responsible for discovering and warning about adverse effects of generic drugs?
    Kesselheim AS; Green MD; Avorn J
    JAMA; 2013 Sep; 310(10):1023-4. PubMed ID: 23922000
    [No Abstract]   [Full Text] [Related]  

  • 12. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From a Viewpoint of Clinical Settings: Pharmacoepidemiology as Reverse Translational Research (rTR)].
    Kawakami J
    Yakugaku Zasshi; 2017; 137(6):681-683. PubMed ID: 28566573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical aspects in comparative benefit-risk assessment: challenges and opportunities for pharmaceutical statisticians.
    Quartey G; Wang J
    Pharm Stat; 2012; 11(1):82-5. PubMed ID: 21997832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of medication side-effects from an economic perspective].
    Segura O; Maldonado C
    Biomedica; 2003 Dec; 23(4):401-7. PubMed ID: 14968918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A proposal for reforming psychologists' training in France and in the European Union].
    Bouchard JP
    Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of epidemiology to the study of drugs.
    Porta MS; Hartzema AG
    Drug Intell Clin Pharm; 1987 Sep; 21(9):741-7. PubMed ID: 3308393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoepidemiology.
    Moore N; Blin P; Droz C
    Handb Exp Pharmacol; 2019; 260():433-451. PubMed ID: 31768750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of health care databases in pharmacoepidemiology.
    Hennessy S
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):311-3. PubMed ID: 16611207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacoepidemiology. An unappreciated tool].
    Vasen W; Fiorentino RM
    Medicina (B Aires); 2006; 66(3):257-62. PubMed ID: 16871916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.